Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welte, K.
Right arrow Articles by Riehm, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welte, K.
Right arrow Articles by Riehm, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia

K Welte, C Zeidler, A Reiter, W Muller, E Odenwald, L Souza and H Riehm

Department of Pediatric Hematology and Oncology, Kinderklinik der Medizinischen Hochschule Hannover, FRG.

Severe congenital neutropenia (SCN) is a disorder of myelopoiesis characterized by severe neutropenia secondary to a maturational arrest at the level of promyelocytes. We treated five patients with SCN with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) for 42 days and subsequently, between 1 and 3 months later, with rhG-CSF for 142 days. The objective was to evaluate the safety and ability of these factors to elicit a neutrophil response. rhGM-CSF was administered at a dose of 3 to 30 micrograms/kg/d (30 to 60 minutes, intravenously). In all patients, a specific, dose-dependent increase in the absolute granulocyte counts was observed. However, in four patients this increase was due to an increase in eosinophils, and in only one patient it was due to an increase in the absolute neutrophil counts (ANC). Subsequently, all patients received rhG-CSF at a dose of 3 to 15 micrograms/kg/d subcutaneously. In contrast to rhGM-CSF treatment, all five patients responded to rhG-CSF during the first 6 weeks of treatment with an increase in the ANC to above 1,000/microL. The level of ANC could be maintained during maintenance treatment. In one patient, the increase in ANC was associated with an improvement of a severe pneumonitis caused by Peptostreptococcus and resistant to antibiotic treatment. No severe bacterial infections occurred in any of the patients during CSF treatment. All patients tolerated rhGM-CSF and rhG-CSF treatment without severe side effects. These results demonstrate the beneficial effect of rhG-CSF in SCN patients.

Volume 75, Issue 5, pp. 1056-1063, 03/01/1990
Copyright © 1990 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
E. Sicinska, Y.-M. Lee, J. Gits, H. Shigematsu, Q. Yu, V. I. Rebel, Y. Geng, C. J. Marshall, K. Akashi, D. M. Dorfman, et al.
Essential Role for Cyclin D3 in Granulocyte Colony-Stimulating Factor-Driven Expansion of Neutrophil Granulocytes
Mol. Cell. Biol., November 1, 2006; 26(21): 8052 - 8060.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
R M James and S E Kinsey
The investigation and management of chronic neutropenia in children
Arch. Dis. Child., October 1, 2006; 91(10): 852 - 858.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Massullo, L. J. Druhan, B. A. Bunnell, M. G. Hunter, J. M. Robinson, C. B. Marsh, and B. R. Avalos
Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes
Blood, May 1, 2005; 105(9): 3397 - 3404.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Kawaguchi, M. Kobayashi, K. Nakamura, N. Konishi, S.-i. Miyagawa, T. Sato, H. Toyoda, Y. Komada, S. Kojima, Y. Todoroki, et al.
Dysregulation of transcriptions in primary granule constituents during myeloid proliferation and differentiation in patients with severe congenital neutropenia
J. Leukoc. Biol., February 1, 2003; 73(2): 225 - 234.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Nakamura, M. Kobayashi, N. Konishi, H. Kawaguchi, S.-i. Miyagawa, T. Sato, H. Toyoda, Y. Komada, S. Kojima, O. Katoh, et al.
Abnormalities of primitive myeloid progenitor cells expressing granulocyte colony-stimulating factor receptor in patients with severe congenital neutropenia
Blood, December 15, 2000; 96(13): 4366 - 4369.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Jeha, K. W. Chan, A. G. Aprikyan, W. K. Hoots, S. Culbert, H. Zietz, D. C. Dale, and M. Albitar
Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia
Blood, November 15, 2000; 96(10): 3647 - 3649.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Kasper, N. Tidow, D. Grothues, and K. Welte
Differential expression and regulation of GTPases (RhoA and Rac2) and GDIs (LyGDI and RhoGDI) in neutrophils from patients with severe congenital neutropenia
Blood, May 1, 2000; 95(9): 2947 - 2953.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Zeidler, K. Welte, Y. Barak, F. Barriga, A. A. Bolyard, L. Boxer, G. Cornu, M. J. Cowan, D. C. Dale, T. Flood, et al.
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation
Blood, February 15, 2000; 95(4): 1195 - 1198.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Konishi, M. Kobayashi, S.-i. Miyagawa, T. Sato, O. Katoh, and K. Ueda
Defective Proliferation of Primitive Myeloid Progenitor Cells in Patients With Severe Congenital Neutropenia
Blood, December 15, 1999; 94(12): 4077 - 4083.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. C. Ward, Y. M. van Aesch, J. Gits, A. M. Schelen, J. P. de Koning, D. van Leeuwen, M. H. Freedman, and I. P. Touw
Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-stimulating Factor (G-CSF) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-CSF Treatment
J. Exp. Med., August 16, 1999; 190(4): 497 - 508.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. H.A. Hermans, C. Antonissen, A. C. Ward, A. E.M. Mayen, R. E. Ploemacher, and I. P. Touw
Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia-derived Mutation in the G-CSF Receptor Gene
J. Exp. Med., February 15, 1999; 189(4): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. G. Hunter and B. R. Avalos
Deletion of a Critical Internalization Domain in the G-CSFR in Acute Myelogenous Leukemia Preceded by Severe Congenital Neutropenia
Blood, January 15, 1999; 93(2): 440 - 446.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Haurie, D. C. Dale, and M. C. Mackey
Cyclical Neutropenia and Other Periodic Hematological Disorders: A Review of Mechanisms and Mathematical Models
Blood, October 15, 1998; 92(8): 2629 - 2640.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Tidow, C. Pilz, B. Teichmann, A. Muller-Brechlin, M. Germeshausen, B. Kasper, P. Rauprich, K.-W. Sykora, and K. Welte
Clinical Relevance of Point Mutations in the Cytoplasmic Domain of the Granulocyte Colony-Stimulating Factor Receptor Gene in Patients With Severe Congenital Neutropenia
Blood, April 1, 1997; 89(7): 2369 - 2375.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. Dong, R. K. Brynes, N. Tidow, K. Welte, B. Lowenberg, and I. P. Touw
Mutations in the Gene for the Granulocyte Colony-Stimulating-Factor Receptor in Patients with Acute Myeloid Leukemia Preceded by Severe Congenital Neutropenia
N. Engl. J. Med., August 24, 1995; 333(8): 487 - 493.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. D. D'Andrea
Cytokine Receptors in Congenital Hematopoietic Disease
N. Engl. J. Med., March 24, 1994; 330(12): 839 - 846.
[Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1990 by American Society of Hematology         Online ISSN: 1528-0020